TARDBP and amyotrophic lateral sclerosis: The pathobiology associated to TDP-43 therefore includes both gain- (GOF) and loss-of-function (LOF) mechanisms and a combination of both is supposed to contribute to the neurodegenerative process in ALS/FTLD diseases [3].